[Search]
[by date] [by subject] [by continent]

Biological Response to Orthpaedic Implants

Johns Hopkins Medical Institutions, Dept. of Orthopaedic Surgery, endorsed by the Society for Biomaterials , Baltimore, MD
April 12-13, 1996

Invited Speakers: Edmund Y.S. Chao, Ph.D.
Professor of Orthopaedic Surgery
Vice Chairman for Research


David S. Hungerford, M.D.
Professor of Orthopaedic Surgery
Chief, Division of Arthritis Surgery


Nozomu Inoue, M.D., Ph.D.
Instructor in Orthopaedic Surgery


Lynne C. Jones, M.S.
Research Associate in Orthopaedic Surgery


John P. Kostuik, M.D.
Professor of Orthopaedic Surgery
and of Neurosurgery
Chief, Spine Division


Edward G. McFarland, M.D.
Assistant Professor of Orthopaedic Surgery
Director, Section of Sports Medicine


Michael A. Mont, M.D.
Assistant Professor of Orthopaedic Surgery


A. Hari Reddi, Ph.D.
Professor of Orthopaedic Surgery
Research Director, Cell Biology Program


Richard N. Stauffer, M.D.
Professor and Chairman
Department of Orthopaedic Surgery





GUEST FACULTY:

Thomas W. Bauer, M.D., Ph.D.
Staff Pathologist
The Cleveland Clinic Foundation
Cleveland, Ohio


Stanley A. Brown, D.Eng.
Biomechanics Engineer
Center for Devices and Radiological Health
Food and Drug Administration
Rockville, Maryland


James E. Dillard
Acting Deputy Director
Division of General and Restorative Devices
Food and Drug Administration
Rockville, Maryland


John Dumbleton, Ph.D., D.Sc.
Senior Vice President
Research and Development Worldwide
Howmedica, Inc.
Rutherford, New Jersey


Peggy A. Lalor, Ph.D.
Senior Research Scientist
Howmedica, Inc.
Rutherford, New Jersey


Steven T. Lin, D.Sc.
Director of Research
Prosthetic Implant Division
Zimmer, Inc.
Warsaw, Indiana


Katharine Merritt, Ph.D.
Biologist
Center for Devices and Radiological Health
Food and Drug Administration
Rockville, Maryland


James M. Pachence, Ph.D.
President
Bio Implant Technologies Corporation
Hopewell, New Jersey


Jack E. Parr, Ph.D.
Vice President of Research and Development
Wright Medical Technology, Inc.
Arlington, Tennessee


Edward C. Shors, Ph.D.
Vice President, Research and Development
Interpore International
Irvine, California


Richard R. Tarr
Vice President of Research and Development
Wright Medical Technology, Inc.
Arlington, Tennessee


L.D. Timmie Topoleski, Ph.D.
Professor of Engineering
University of Maryland Baltimore County
Baltimore, Maryland


Program:
Technological development in material science and engineering has expanded the use of biomaterials in orthopaedics. Conventional implants and fixation devices are being improved and new biologic grafting materials as well as novel biological reagents are being tested for clinical application.



This symposium provides and overview of the current and new applications of biomaterials in orthopaedics. It also presents state of the art laboratory methods and models toe valuate the utility of biomaterials for clinical use. The course is directed towards orthopaedic surgeons, orthopaedists, biologists, bioengineers, biomaterial scientists, as well as students in these fields.



The course is divided into four sections. The first section will present current and new materials used in orthopaedics. The second section discusses physico-chemical changes in implants in vivo. The third section will focus on novel applications of implants and devices in orthopaedics. Cellular and tissue response to biomaterials will be addressed in the fourth section. The course will consist of a series of lectures from experts in the field of orthpaedics, material science, engineering and immunology as well as representatives from manufacturing industry and regulatory agencies. Dr. Thomas W. Bauer, a renown pathologist and researcher will give the Lee H. Riley, Jr. keynote lecture.


COURSE OBJECTIVES



Upon completion of this course, participants should be:



* familiar with current and new technological advancement on the use of biomaterials.



* able to evaluate the utility of biomaterials for orthopaedic application.



* able to understand the cellular tissue interaction with orthopaedic biomaterials.

Registration :


	Registration Fee				 $275
	Residents, Fellows, and Students 	$140
		(with letter from department chairperson verifying status.)

	Please note that on-site registrations will be assessed a $15 charge.


The registration fee, which is payable in advance, includes instructional materials, continental breakfasts, and
refreshment breaks. Foreign payments must be made on a U.S. bank.



Cancellation Policy: An administrative fee of $35 will be retained on all refunds. Refunds are not possible unless
notice of cancellation is received one business day prior to the first day of the course. Refunds will be processed
upon receipt of a cancellation letter. The Johns Hopkins University reserves the right to cancel this course at any
time. In this event, the full registration fee will be returned to the registrant.



CONTINUING MEDICAL EDUCATION CREDIT


The Johns Hopkins University School of Medicine is accredited by the
Accreditation Council for Continuing Medical Education to sponsor medical education
for physicians.



The Johns Hopkins University designates this continuing medical education activity for
13 credit hours in Category I of the Physician's Recognition Award of the American
Medical Association.



This program has been approved for 1.3 Continuing Education units.

Deadline for Abstracts: na

Email for Requests and Registration: dheaphy@SOM.adm.jhu.edu

Posted by: A Thousand Words Media Host: proxy.bellatlantic.com date: March 18, 96 15:30:58
Generated by meetings and positions 1.0 by Kai Garlipp